Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
Conte PF, Gennari A, Donati S, Salvadori B, Baldini E, Bengala C, Pazzagli I, Orlandini C, Danesi R, Fogli S, Del Tacca M.
Conte PF, et al.
Breast Cancer Res Treat. 2001 Jul;68(2):171-9. doi: 10.1023/a:1011945623464.
Breast Cancer Res Treat. 2001.
PMID: 11688520
Clinical Trial.